Literature DB >> 16139470

Normative Symbol Digit Modalities Test performance in a community-based sample.

Laura K Sheridan1, Hiram E Fitzgerald, Kenneth M Adams, Joel T Nigg, Michelle M Martel, Leon I Puttler, Maria M Wong, Robert A Zucker.   

Abstract

The Symbol Digit Modalities Test is a substitution task that is the inverse of the Digit Symbol Test. The familiar task of filling numbers in boxes, and the availability of an oral administration, make this a popular screening instrument for brain impairment. Normative data were previously reported for a variety of clinical groups, but complete information on non-clinical samples across age, education, gender, and socioeconomic status is limited. The present study examines the performance of a community-dwelling control sample across age, education, gender, and income groupings. In a multivariate model, these four variables did not impact test performance. These results support the utilization of the SDMT as a robust screening test for adult neuropsychological impairment.

Entities:  

Mesh:

Year:  2005        PMID: 16139470     DOI: 10.1016/j.acn.2005.07.003

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  103 in total

1.  Effects of APOE promoter polymorphism on the topological organization of brain structural connectome in nondemented elderly.

Authors:  Ni Shu; Xin Li; Chao Ma; Junying Zhang; Kewei Chen; Ying Liang; Yaojing Chen; Zhanjun Zhang
Journal:  Hum Brain Mapp       Date:  2015-08-28       Impact factor: 5.038

2.  Modified-Symbol Digit Modalities Test for African Americans, Caribbean Black Americans, and non-Latino Whites: nationally representative normative data from the National Survey of American Life.

Authors:  Hector M González; Keith E Whitfield; Brady T West; David R Williams; Peter A Lichtenberg; James S Jackson
Journal:  Arch Clin Neuropsychol       Date:  2007-05-09       Impact factor: 2.813

3.  Neuropsychological latent classes at enrollment and postmortem neuropathology.

Authors:  Andrea R Zammit; Charles B Hall; David A Bennett; Ali Ezzati; Mindy J Katz; Graciela Muniz-Terrera; Richard B Lipton
Journal:  Alzheimers Dement       Date:  2019-08-13       Impact factor: 21.566

4.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.

Authors:  Susan De Santi; Elizabeth Pirraglia; William Barr; James Babb; Schantel Williams; Kimberley Rogers; Lidia Glodzik; Miroslaw Brys; Lisa Mosconi; Barry Reisberg; Steven Ferris; Mony J de Leon
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

5.  SORL1 rs1699102 polymorphism modulates age-related cognitive decline and gray matter volume reduction in non-demented individuals.

Authors:  He Li; Chenlong Lv; Caishui Yang; Dongfeng Wei; Kewei Chen; Shaowu Li; Zhanjun Zhang
Journal:  Eur J Neurol       Date:  2016-10-25       Impact factor: 6.089

6.  The influence of differences in neurocognitive function on lower limb kinematics, kinetics, and muscle activity during an unanticipated cutting motion.

Authors:  Satoshi Shibata; Masahiro Takemura; Shumpei Miyakawa
Journal:  Phys Ther Res       Date:  2018-08-30

7.  Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?

Authors:  Jessica Burggraaff; Dirk L Knol; Bernard M J Uitdehaag
Journal:  Eur Neurol       Date:  2017-03-21       Impact factor: 1.710

8.  Exercise, fitness, and neurocognitive function in older adults: the "selective improvement" and "cardiovascular fitness" hypotheses.

Authors:  Ann L Smiley-Oyen; Kristin A Lowry; Sara J Francois; Marian L Kohut; Panteleimon Ekkekakis
Journal:  Ann Behav Med       Date:  2008-09-30

9.  Normative data for the digit-letter substitution task in school children.

Authors:  Balaram Pradhan; Hr Nagendra
Journal:  Int J Yoga       Date:  2009-07

10.  Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.

Authors:  Ulla Knorr; Maj Vinberg; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Anders Gade; Eva Haastrup; Olaf Paulson; Jørn Wetterslev; Christian Gluud; Ulrik Gether; Lars Kessing
Journal:  Trials       Date:  2009-08-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.